Questionnaire on Quality of Life of Chinese CML Patients
Tyrosine kinase inhibitors (TKIs) have dramatically changed the history of chronic myeolgenous leukemia (CML) treatment. Most of patients can achieve the survival as long as the healthy people, if they receive the proper treatment and standard monitoring.
Lifelong TKI medication is still the well-known recommended treatment for CML in the world and stopping TKI therapy is only restricted in clinical trials. However, the decline of quality of life caused by TKI side effects has aroused more and more attention of doctors and patients. In order to know the side effects of TKI medication in Chinese CML patients, their impacts on quality of life and the patients' common concerns, this questionnaire is designed to help doctors make better therapy for Chinese CML patients.
I. Fill in the blank and choose the best answer
Name:
(optional) Date of filling 
